March 29 - Apr 3, 2019
Georgia World Congress Center
Atlanta, Georgia, USA
Abstract submission deadline: Thursday, November 15
Friday, March 29-Wednesday, April 3, 2019Georgia World Congress CenterAtlanta, Georgia
Abstract Submission Deadline: Thursday, Nov. 15, 2018, 11:59 p.m. ETLate-Breaking and Clinical Trials Abstract Submission Deadline: Thursday, Jan. 10, 2019, 11:59 p.m. ET
Program Committee ChairJohn D. Carpten, USC Keck School of Medicine, Los Angeles, California
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. More information about the AACR Annual Meeting 2019 will be available online and in the Call for Abstracts in late August 2018.
Program Committee Vice ChairsKenneth C. Anderson, Dana-Farber Cancer Institute, Boston, MassachusettsMarcia R. Cruz-Correa, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto RicoTodd R. Golub, Broad Institute of MIT and Harvard, Cambridge, MassachusettsStephen D. Hursting, University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaPatricia M. LoRusso, Yale Cancer Center, New Haven, ConnecticutRichard M. Marais, Cancer Research UK Manchester Institute, Manchester, United KingdomAviv Regev, Massachusetts Institute of Technology and Broad Institute of MIT and Harvard, Cambridge, MassachusettsAntoni Ribas, UCLA Medical Center, Los Angeles, CaliforniaBrian M. Rivers, Morehouse School of Medicine, Atlanta, GeorgiaDavid A. Tuveson, Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, New York
Program Committee CochairsNilofer S. Azad, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MarylandAnna D. Barker, Arizona State University, Scottsdale, ArizonaJulian Blagg, Institute of Cancer Research, Sutton, Surrey, United KingdomJohn M. Carethers, University of Michigan, Ann Arbor, MichiganLouis Chesler, Institute of Cancer Research, Sutton, United KingdomDavid C. Christiani, Harvard Medical School, Boston, MassachusettsMario P. Colombo, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyJoseph N. Contessa, Yale University, New Haven, ConnecticutLisa M. Coussens, OHSU Knight Cancer Institute, Portland, OregonDavid W. Craig, USC Keck School of Medicine, Los Angeles, CaliforniaChristina Curtis, Stanford University, Stanford, CaliforniaRiccardo Dalla-Favera, Columbia University Institute for Cancer Genetics, New York, New YorkCaroline Dive, Cancer Research UK Manchester Institute, Manchester, United KingdomLaura Fejerman, University of California, San Francisco, San Francisco, CaliforniaKevin L. Gardner, Columbia University, New York, New YorkDavid R. Gius, Northwestern University, Chicago, IllinoisMithat Gönen, Memorial Sloan Kettering Cancer Center, New York, New YorkJennifer Rubin Grandis, University of California, San Francisco, San Francisco, CaliforniaJohn D. Groopman, Johns Hopkins University School of Public Health, Baltimore, MarylandSusan E. Hankinson, University of Massachusetts Amherst, Amherst, MassachusettsJamie N. Holloway, Georgetown University, Washington, District of ColumbiaCatriona H.M. Jamieson, UCSD Moores Cancer Center, La Jolla, CaliforniaPeter Kuhn, University of Southern California, Los Angeles, CaliforniaSherene Loi, Peter MacCallum Cancer Centre, Camberwell, Victoria, AustraliaThomas J. Lynch, Jr., Bristol-Myers Squibb Co., New York, New YorkCrystal L. Mackall, Stanford University School of Medicine, Stanford, CaliforniaTak W. Mak, Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, CanadaHiroyuki Mano, National Cancer Center Research Institute, Tokyo, JapanGordon B. Mills, OHSU Knight Cancer Institute, Portland, OregonLisa A. Newman, Henry Ford Health System, Detroit, MichiganKunle Odunsi, Roswell Park Cancer Institute, Buffalo, New YorkMoshe Oren, Weizmann Institute of Science, Rehovot, IsraelKlaus Pantel, University Medical Center Hamburg, Hamburg, GermanyWilliam Pao, Roche Pharma Research and Early Development, Basel, SwitzerlandLuis F. Parada, Memorial Sloan Kettering Cancer Center, New York, New YorkElectra D. Paskett, Ohio State University Comprehensive Cancer Center, Columbus, OhioEdith A. Perez, Genentech, Inc., South San Francisco, CaliforniaEric H. Rubin, Merck Research Laboratories, North Wales, PennsylvaniaAnil K. Rustgi, University of Pennsylvania School of Medicine, Philadelphia, PennsylvaniaPatty Spears, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North CarolinaVictor E. Velculescu, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MarylandJennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, TexasE. John Wherry III, University of Pennsylvania, Philadelphia, PennsylvaniaLouis M. Weiner, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia
About the LocationAtlanta, the capital of and the most populous city in Georgia, is a cultural and economic center of the state and the ninth largest metropolitan area in the United States. The city is the primary transportation hub of the Southeastern United States, via highway, railroad, and air, with Hartsfield–Jackson Atlanta International Airport being the world's busiest airport since 1998. Atlanta is home to nationally renowned private colleges and universities, most notably Emory University, a leading liberal arts and research institution that ranks among the top 20 schools in the United States. Emory University – home to Winship Cancer Institute – also operates Emory Healthcare, the largest health care system in Georgia.
Continuing Medical Education Activity—AMA PRA Category 1 CreditsTM available